Literature DB >> 9888512

SF-1 and the transcriptional regulation of the human ACTH receptor gene.

D Naville1, A Penhoat, R Marchal, P Durand, M Bégeot.   

Abstract

The adrenocorticotropin receptor or ACTH-R which is the type 2 among the melanocortin receptor family is almost exclusively expressed in the adrenal cortex, reflecting a high degree of tissue specificity. In human cultured adrenocortical cells, we have previously reported that ACTH in contrast to most of the peptide hormones, is able to up-regulate the number of its own receptors through an increase of the transcriptional activity of the encoding gene. Three putative SF-1 binding sites are present in the sequence of the human ACTH-R gene promoter at -35 (SF-35), -98 (SF-98) and -209 (SF-209). By EMSA studies, we demonstrated that these sites effectively bind SF-1 protein. After transient transfection of H295R cells using a construct containing the first 263 bp upstream of the transcriptional start site, in front of the luciferase gene in the pGL3 vector, we demonstrated the involvement of all three SF-1 sites to confer maximal constitutive activity to a proximal region of the hACTH-R gene promoter. Only SF-35 and SF-98 play a role in cAMP-induced regulation of this gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888512     DOI: 10.3109/07435809809032620

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  2 in total

1.  SF-1 a key player in the development and differentiation of steroidogenic tissues.

Authors:  Pierre Val; Anne-Marie Lefrançois-Martinez; Georges Veyssière; Antoine Martinez
Journal:  Nucl Recept       Date:  2003-09-18

2.  Effect of ACTH and hCG on the Expression of Gonadotropin-Inducible Ovarian Transcription Factor 1 (Giot1) Gene in the Rat Adrenal Gland.

Authors:  Karol Jopek; Marianna Tyczewska; Manjunath Ramanjaneya; Marta Szyszka; Piotr Celichowski; Paulina Milecka; Ludwik K Malendowicz; Marcin Rucinski
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.